Next Generation Sequencing in MPNs. Lessons from the Past and Prospects for Use as Predictors of Prognosis and Treatment Responses

The myeloproliferative neoplasms (MPNs) are acquired hematological stem cell neoplasms characterized by driver mutations in JAK2, CALR, or MPL. Additive mutations may appear in predominantly epigenetic regulator, RNA splicing and signaling pathway genes. These molecular mutations are a hallmark of d...

Descripción completa

Detalles Bibliográficos
Autor principal: Skov, Vibe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464861/
https://www.ncbi.nlm.nih.gov/pubmed/32781570
http://dx.doi.org/10.3390/cancers12082194

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7464861/
https://www.ncbi.nlm.nih.gov/pubmed/32781570
http://dx.doi.org/10.3390/cancers12082194

Ejemplares similares